Johnson & Johnson to acquire Proteologix for $850 million

(Reuters) – Johnson & Johnson on Thursday said it would acquire privately held Proteologix for $850 million in cash, with potential for an additional milestone payment.

(Reporting by Sriparna Roy in Bengaluru; Editing by Anil D’Silva)